Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare Advantage
Abstract Approximately half of Medicare beneficiaries are enrolled in Medicare Advantage (MA), a private plan alternative to traditional Medicare (TM). Yet little is known about diagnosed dementia rates among MA enrollees, limiting population estimates. All (100%) claims of Medicare beneficiaries us...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-07-01
|
| Series: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/dad2.12472 |
| _version_ | 1827805730055389184 |
|---|---|
| author | Sidra Haye Johanna Thunell Geoffrey Joyce Patricia Ferido Bryan Tysinger Mireille Jacobson Julie Zissimopoulos |
| author_facet | Sidra Haye Johanna Thunell Geoffrey Joyce Patricia Ferido Bryan Tysinger Mireille Jacobson Julie Zissimopoulos |
| author_sort | Sidra Haye |
| collection | DOAJ |
| description | Abstract Approximately half of Medicare beneficiaries are enrolled in Medicare Advantage (MA), a private plan alternative to traditional Medicare (TM). Yet little is known about diagnosed dementia rates among MA enrollees, limiting population estimates. All (100%) claims of Medicare beneficiaries using encounter data for MA and claims for TM for the years 2015 to 2018 were used to quantify diagnosed dementia prevalence and incidence rates in MA, compare rates to TM, and provide estimates for the entire Medicare population and for different racial/ethnic populations. In 2017, dementia incidence and prevalence among MA beneficiaries were 2.54% (95% confidence interval [CI]: 2.53 to 2.55) and 7.04% (95% CI: 7.03 to 7.06). Comparison to TM adjusted for sociodemographic and health differences among beneficiaries in MA and TM; the prevalence of diagnosed dementia among beneficiaries in MA was lower (7.1%; 95% CI: 7.12 to 7.13) than in TM (8.7%; 95% CI: 8.71 to 8.72). The diagnosed dementia incidence rate was also lower in MA (2.50%; 95% CI: 2.50 to 2.50) compared to TM (2.99%; 95% CI: 2.99 to 2.99). There were lower rates in MA compared to TM for men and women and White, Black, Hispanic, Asian, American Indian/Alaska Native persons. Diagnosed dementia prevalence and incidence for the entire Medicare population was 7.9% (95% CI: 7.91 to 7.93) and 2.8% (95% CI: 2.77 to 2.78). Lower diagnosed dementia rates in MA compared to TM may exacerbate racial/ethnic disparities in diagnosed dementia. Rates tracked over time will provide understanding of the impact on dementia diagnosis of 2020 MA risk adjustment for dementia. |
| first_indexed | 2024-03-11T21:30:22Z |
| format | Article |
| id | doaj.art-f28ce47fda364e0e8510fdc9b3b84836 |
| institution | Directory Open Access Journal |
| issn | 2352-8729 |
| language | English |
| last_indexed | 2024-03-11T21:30:22Z |
| publishDate | 2023-07-01 |
| publisher | Wiley |
| record_format | Article |
| series | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
| spelling | doaj.art-f28ce47fda364e0e8510fdc9b3b848362023-09-27T11:20:33ZengWileyAlzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring2352-87292023-07-01153n/an/a10.1002/dad2.12472Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare AdvantageSidra Haye0Johanna Thunell1Geoffrey Joyce2Patricia Ferido3Bryan Tysinger4Mireille Jacobson5Julie Zissimopoulos6USC Price School of Public Policy University of Southern California Los Angeles California USAUSC Price School of Public Policy University of Southern California Los Angeles California USALeonard D. Schaeffer Center for Health Policy & Economics University of Southern California Los Angeles California USALeonard D. Schaeffer Center for Health Policy & Economics University of Southern California Los Angeles California USAUSC Price School of Public Policy University of Southern California Los Angeles California USALeonard D. Schaeffer Center for Health Policy & Economics University of Southern California Los Angeles California USAUSC Price School of Public Policy University of Southern California Los Angeles California USAAbstract Approximately half of Medicare beneficiaries are enrolled in Medicare Advantage (MA), a private plan alternative to traditional Medicare (TM). Yet little is known about diagnosed dementia rates among MA enrollees, limiting population estimates. All (100%) claims of Medicare beneficiaries using encounter data for MA and claims for TM for the years 2015 to 2018 were used to quantify diagnosed dementia prevalence and incidence rates in MA, compare rates to TM, and provide estimates for the entire Medicare population and for different racial/ethnic populations. In 2017, dementia incidence and prevalence among MA beneficiaries were 2.54% (95% confidence interval [CI]: 2.53 to 2.55) and 7.04% (95% CI: 7.03 to 7.06). Comparison to TM adjusted for sociodemographic and health differences among beneficiaries in MA and TM; the prevalence of diagnosed dementia among beneficiaries in MA was lower (7.1%; 95% CI: 7.12 to 7.13) than in TM (8.7%; 95% CI: 8.71 to 8.72). The diagnosed dementia incidence rate was also lower in MA (2.50%; 95% CI: 2.50 to 2.50) compared to TM (2.99%; 95% CI: 2.99 to 2.99). There were lower rates in MA compared to TM for men and women and White, Black, Hispanic, Asian, American Indian/Alaska Native persons. Diagnosed dementia prevalence and incidence for the entire Medicare population was 7.9% (95% CI: 7.91 to 7.93) and 2.8% (95% CI: 2.77 to 2.78). Lower diagnosed dementia rates in MA compared to TM may exacerbate racial/ethnic disparities in diagnosed dementia. Rates tracked over time will provide understanding of the impact on dementia diagnosis of 2020 MA risk adjustment for dementia.https://doi.org/10.1002/dad2.12472Alzheimer's diseasedementiadiagnosisMedicareMedicare Advantage |
| spellingShingle | Sidra Haye Johanna Thunell Geoffrey Joyce Patricia Ferido Bryan Tysinger Mireille Jacobson Julie Zissimopoulos Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare Advantage Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring Alzheimer's disease dementia diagnosis Medicare Medicare Advantage |
| title | Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare Advantage |
| title_full | Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare Advantage |
| title_fullStr | Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare Advantage |
| title_full_unstemmed | Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare Advantage |
| title_short | Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare Advantage |
| title_sort | estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional medicare and medicare advantage |
| topic | Alzheimer's disease dementia diagnosis Medicare Medicare Advantage |
| url | https://doi.org/10.1002/dad2.12472 |
| work_keys_str_mv | AT sidrahaye estimatesofdiagnoseddementiaprevalenceandincidenceamongdiversebeneficiariesintraditionalmedicareandmedicareadvantage AT johannathunell estimatesofdiagnoseddementiaprevalenceandincidenceamongdiversebeneficiariesintraditionalmedicareandmedicareadvantage AT geoffreyjoyce estimatesofdiagnoseddementiaprevalenceandincidenceamongdiversebeneficiariesintraditionalmedicareandmedicareadvantage AT patriciaferido estimatesofdiagnoseddementiaprevalenceandincidenceamongdiversebeneficiariesintraditionalmedicareandmedicareadvantage AT bryantysinger estimatesofdiagnoseddementiaprevalenceandincidenceamongdiversebeneficiariesintraditionalmedicareandmedicareadvantage AT mireillejacobson estimatesofdiagnoseddementiaprevalenceandincidenceamongdiversebeneficiariesintraditionalmedicareandmedicareadvantage AT juliezissimopoulos estimatesofdiagnoseddementiaprevalenceandincidenceamongdiversebeneficiariesintraditionalmedicareandmedicareadvantage |